|
Ken Bair is currently the Senior Vice President of Research and Development at EntreMed, Inc. He serves as a consultant to the biopharmaceutical industry and various venture capital firms. He was recently Senior Vice President and Head of BioPharma research at Chiron BioPharmaceuticals, including chemistry, biology, applied biochemistry and discovery projects. Dr. Bair joined Chiron from Pharmacia Corporation, where he was Vice President, Discovery Oncology. He also led oncology research programs during five years with Novartis Pharmaceuticals and five years with Sandoz pharmaceuticals. He began his pharmaceutical career as a research scientist with Burroughs Wellcome Co., where over 14 years he led programs in tumor biology, cell biology and organic chemistry. Among his academic distinctions, Dr. Bair was a Damon Runyon-Walter Winchell Cancer Foundation Postdoctoral Fellow at the Massachusetts Institute of Technology. He holds a Ph.D. in organic chemistry from Brandeis University and master’s and bachelor’s degrees from Wayne State University. | 